- ICH GCP
- US-Register für klinische Studien
- Klinische Studie NCT06001918
Klinische Studie zum Nectero EAST System (stAAAble)
Randomisierte kontrollierte klinische Studie (RCT) des Nectero EAST-Systems für kleine bis mittelgroße abdominale Aortenaneurysmen (AAA) Stabilisierung: Bewertung der Wirksamkeit.
The purpose of this randomized clinical trial is to treat patients with small to mid-sized abdominal aortic aneurysms (AAA), maximum diameter of 3.5 cm to 5.0 cm, using a locally delivered, single-dose endovascular treatment. The main question the study aims to answer is to demonstrate efficacy of the product for stabilization of these small to mid-sized AAA.The study will compare the treatment group to the typical standard of care for these patients, surveillance. All subjects will be followed at designated intervals at 30/60 days, 6, 12, 18 and 24 months with continued follow-up annually for up to 5 years.
Studienübersicht
Status
Bedingungen
Intervention / Behandlung
Studientyp
Einschreibung (Geschätzt)
Phase
- Phase 2
- Phase 3
Kontakte und Standorte
Studienkontakt
- Name: Charlene Knape
- Telefonnummer: 866-755-4744
- E-Mail: cknape@necteromedical.com
Studieren Sie die Kontaktsicherung
- Name: Tracy Roberts
- Telefonnummer: (303)3964603
- E-Mail: troberts@necteromedical.com
Studienorte
-
-
New South Wales
-
Randwick, New South Wales, Australien, 2031
- Rekrutierung
- Prince of Wales Private Hospital- POW Vascular Institute
-
Hauptermittler:
- Ramon Varcoe
-
Kontakt:
- Jade Goh
- Telefonnummer: 04 87 369 396
- E-Mail: pow.vascular.institute@gmail.com
-
-
-
-
-
Auckland, Neuseeland, 1023
- Rekrutierung
- Auckland City Hospital
-
Kontakt:
- Cynthia Corne
- Telefonnummer: 21505 +64 9 307 4949
- E-Mail: CorneC@adhb.govt.nz
-
Hauptermittler:
- Andrew Holden, A/Prof
-
-
-
-
Arizona
-
Scottsdale, Arizona, Vereinigte Staaten, 85258
- Rekrutierung
- Honor Health Scottsdale Shea Medical Center
-
Hauptermittler:
- Hasan Aldailami, MD
-
Kontakt:
- HonorHealth Cardiovascular Research
- Telefonnummer: 480-323-1046
-
-
Colorado
-
Aurora, Colorado, Vereinigte Staaten, 80045
- Aktiv, nicht rekrutierend
- University of Colorado
-
-
District of Columbia
-
Washington D.C., District of Columbia, Vereinigte Staaten, 20010
- Rekrutierung
- Medstar Washington Hospital Center
-
Hauptermittler:
- Steven Abramowitz, MD
-
Kontakt:
- Kassaye Sesaba, MD
- Telefonnummer: 202-877-7452
- E-Mail: Kassaye.T.Sesaba@medstar.net
-
Kontakt:
- Suman Singh, MD
- Telefonnummer: (202) 877-8475
- E-Mail: Suman.Singh@Medstar.net
-
-
Florida
-
Delray Beach, Florida, Vereinigte Staaten, 33446
- Rekrutierung
- Prime Vascular Institute
-
Hauptermittler:
- Joseph Ricotta, MD
-
Kontakt:
- Jordan Sprechman
- Telefonnummer: 561-495-3145
- E-Mail: Jordan.Sprechman@tenethealth.com
-
Kontakt:
- Alexia Medick
- E-Mail: Alexia.Medick@tenethealth.com
-
-
Georgia
-
Augusta, Georgia, Vereinigte Staaten, 30912
- Rekrutierung
- Medical College of Georgia
-
Hauptermittler:
- William Jordan, MD
-
Kontakt:
- Natasha Flores
- E-Mail: nflores@augusta.edu
-
Kontakt:
- Candelario Laserna
- Telefonnummer: 706-721-2199
- E-Mail: calaserna@augusta.edu
-
-
Illinois
-
Chicago, Illinois, Vereinigte Staaten, 60637
- Rekrutierung
- University of Chicago
-
Kontakt:
- MacKenton Johnson
- Telefonnummer: 773-795-3639
- E-Mail: mackenton@bsd.uchicago.edu
-
Hauptermittler:
- Ross Milner, MD
-
Elk Grove, Illinois, Vereinigte Staaten, 60007
- Noch keine Rekrutierung
- Ascension Alexian Brothers
-
Hauptermittler:
- Jack Chamberlin, MD
-
-
Maine
-
Scarborough, Maine, Vereinigte Staaten, 04074
- Rekrutierung
- MaineMed Vascular Surgery
-
Hauptermittler:
- Kristina Giles, MD
-
Kontakt:
- Kathryn Ackermann
- E-Mail: kathryn.ackermann@mainehealth.org
-
-
Massachusetts
-
Boston, Massachusetts, Vereinigte Staaten, 02114
- Rekrutierung
- Massachusetts General Hospital
-
Hauptermittler:
- Nikolaos Zacharias, MD
-
Kontakt:
- Bonnie Chen
- E-Mail: BCHEN13@mgh.harvard.edu
-
Boston, Massachusetts, Vereinigte Staaten, 02215
- Rekrutierung
- Beth Israel Deaconess Medical Center
-
Hauptermittler:
- Marc Schermerhorn, MD
-
Kontakt:
- Monica Goyal
- Telefonnummer: 617-632-7534
- E-Mail: mgoyal@bidmc.harvard.edu
-
Kontakt:
- Fernando Moreno
- E-Mail: fmoreno@bidmc.harvard.edu
-
Worcester, Massachusetts, Vereinigte Staaten, 01655
- Rekrutierung
- University of Massachusetts
-
Kontakt:
- Shauneen Valliere
- E-Mail: shauneen.valliere@umassmed.edu
-
Hauptermittler:
- Andres Schanzer, MD
-
-
Michigan
-
Royal Oak, Michigan, Vereinigte Staaten, 48073
- Rekrutierung
- Beaumont Health
-
Hauptermittler:
- Graham Long, MD
-
Kontakt:
- Lisa Bliss
- E-Mail: lisa.bliss@corewellhealth.org
-
-
Missouri
-
St Louis, Missouri, Vereinigte Staaten, 63110
- Rekrutierung
- Washington University School of Medicine
-
Hauptermittler:
- Luis Sanchez, MD
-
Kontakt:
- Briana K Langrehr, BSN
- E-Mail: briana.l@wustl.edu
-
-
Nebraska
-
Omaha, Nebraska, Vereinigte Staaten, 68198
- Rekrutierung
- University of Nebraska Medical Center
-
Hauptermittler:
- Jonathan Thompson, MD
-
Kontakt:
- Jarod Phillips
- E-Mail: jarphillips@unmc.edu
-
-
New Hampshire
-
Lebanon, New Hampshire, Vereinigte Staaten, 03766
- Rekrutierung
- Dartmouth Hitchcock Medical Center
-
Hauptermittler:
- Rebecca Scully, MD
-
Kontakt:
- Pauline Sirrell
- E-Mail: pauline.sirrell@hitchcock.org
-
-
New York
-
Rochester, New York, Vereinigte Staaten, 14642
- Rekrutierung
- University of Rochester
-
Kontakt:
- Mary Bourret
- E-Mail: Mary_Bourret@URMC.Rochester.edu
-
Hauptermittler:
- Doran Mix, MD
-
Stony Brook, New York, Vereinigte Staaten, 11794
- Noch keine Rekrutierung
- Stony Brook Medicine
-
Hauptermittler:
- Rabih Chaer, MD
-
Kontakt:
- Daria Shavarina
- E-Mail: Daria.Shavarina@stonybrookmedicine.edu
-
-
North Carolina
-
Durham, North Carolina, Vereinigte Staaten, 27710
- Rekrutierung
- Duke University Medical Center
-
Hauptermittler:
- Chandler Long, MD
-
Kontakt:
- Ellen Burkett
- Telefonnummer: (919)681-1878
- E-Mail: ellen.jones@duke.edu
-
-
Ohio
-
Cincinnati, Ohio, Vereinigte Staaten, 45219
- Rekrutierung
- The Christ Hospital
-
Kontakt:
- Jamie Elkins
- E-Mail: Jamie.Elkins@thechristhospital.com
-
Hauptermittler:
- Geoff Answini, MD
-
Cleveland, Ohio, Vereinigte Staaten, 44106
- Rekrutierung
- University Hospitals Cleveland
-
Hauptermittler:
- Jae Cho, MD
-
Kontakt:
- Amy Kluge
- E-Mail: Amy.Kluge@UHhospitals.org
-
Cleveland, Ohio, Vereinigte Staaten, 44195
- Rekrutierung
- Cleveland Clinic
-
Hauptermittler:
- Francis Caputo, MD
-
Kontakt:
- Laurie Ann Moennich
- E-Mail: MOENNIL@ccf.org
-
Columbus, Ohio, Vereinigte Staaten, 43210
- Rekrutierung
- The Ohio State University Wexner Medical Center
-
Kontakt:
- Subh Das
- Telefonnummer: 614-366-6596
- E-Mail: subhashish.das@osumc.edu
-
Hauptermittler:
- Kristine Orion, MD
-
Columbus, Ohio, Vereinigte Staaten, 43214
- Rekrutierung
- Ohio Health Riverside
-
Hauptermittler:
- Joseph Campbell, MD
-
Kontakt:
- Regan Moran
- E-Mail: Regan.Moran@ohiohealth.com
-
-
Oklahoma
-
Tulsa, Oklahoma, Vereinigte Staaten, 74104
- Rekrutierung
- Oklahoma Heart Institute
-
Hauptermittler:
- Julia Chen, MD
-
Kontakt:
- Tia Whitaker
- E-Mail: Tia.Whitaker@hillcrest.com
-
-
Oregon
-
Portland, Oregon, Vereinigte Staaten, 97239
- Rekrutierung
- Portland VA Medical Center
-
Hauptermittler:
- Matthew Koopmann, MD
-
Kontakt:
- Rachel Nelson
- E-Mail: Rachel.Nelson1@va.gov
-
-
Pennsylvania
-
Bethlehem, Pennsylvania, Vereinigte Staaten, 18015
- Rekrutierung
- St. Luke's University Health Network
-
Hauptermittler:
- Sharvil Sheth, MD
-
Kontakt:
- Jena Hagerty
- Telefonnummer: 484-658-4982
- E-Mail: Jena.Hagerty@sluhn.org
-
Philadelphia, Pennsylvania, Vereinigte Staaten, 19104
- Rekrutierung
- Hospital of the University of Pennsylvania
-
Kontakt:
- Carolina Reyes
- Telefonnummer: 215-615-8036
- E-Mail: carolina.reyes1@pennmedicine.upenn.edu
-
Hauptermittler:
- Grace Wang, MD
-
Philadelphia, Pennsylvania, Vereinigte Staaten, 19107
- Rekrutierung
- Jefferson Clinical Research Institute
-
Kontakt:
- Jona Shperdheja
- E-Mail: Jona.Shperdheja@jefferson.edu
-
Hauptermittler:
- Michael Nooromid, MD
-
Pittsburgh, Pennsylvania, Vereinigte Staaten, 15219
- Rekrutierung
- University of Pittsburgh Medical Center
-
Kontakt:
- Judith Brimmeier
- E-Mail: brimmeierja@upmc.edu
-
Hauptermittler:
- Raymond Eid, MD
-
-
South Carolina
-
Greenville, South Carolina, Vereinigte Staaten, 29605
- Rekrutierung
- Prisma Health
-
Hauptermittler:
- Mark P Androes, MD
-
Kontakt:
- Nikita Kasinger
- E-Mail: Nikita.Kasinger@PrismaHealth.org
-
Kontakt:
- Maggie Salle
- E-Mail: Margaret.Salle@PrismaHealth.org
-
-
South Dakota
-
Sioux Falls, South Dakota, Vereinigte Staaten, 57108
- Rekrutierung
- North Central Heart - A Division of Avera Heart Hospital
-
Hauptermittler:
- Michael Bacharach, MD
-
Kontakt:
- Patty Eisenbraun, RN
- Telefonnummer: 605-977-5336
- E-Mail: peisenbraun@ncheart.com
-
-
Tennessee
-
Nashville, Tennessee, Vereinigte Staaten, 37232
- Rekrutierung
- Vanderbilt University Medical Center
-
Hauptermittler:
- John Curci, MD
-
Kontakt:
- Celia Nunez
- E-Mail: celia.m.nunez@vumc.org
-
Kontakt:
- Jennifer Scott
- E-Mail: jennifer.scott@vumc.org
-
Nashville, Tennessee, Vereinigte Staaten, 37212
- Noch keine Rekrutierung
- VA Tennessee Valley Healthcare System
-
Hauptermittler:
- John Curci, MD
-
Kontakt:
- Sohpia Miner
- E-Mail: Sophia.Miner@va.gov
-
-
Texas
-
Houston, Texas, Vereinigte Staaten, 77004
- Rekrutierung
- Houston Healthcare
-
Hauptermittler:
- Kristofer Charlton-Ouw, MD
-
Kontakt:
- Swathi Potla
- E-Mail: swathi.potla@hcahealthcare.com
-
Plano, Texas, Vereinigte Staaten, 75093
- Rekrutierung
- Baylor Scott & White Medical Center
-
Hauptermittler:
- William Shutze, MD
-
Kontakt:
- Saba Arianpour
- E-Mail: Saba.Arianpour@BSWHealth.org
-
-
Utah
-
Salt Lake City, Utah, Vereinigte Staaten, 84132
- Rekrutierung
- University of Utah Hospital
-
Kontakt:
- Julie Hales
- E-Mail: Julie.Hales@hsc.utah.edu
-
Hauptermittler:
- Cali Johnson, MD
-
-
Virginia
-
Fairfax, Virginia, Vereinigte Staaten, 22031
- Rekrutierung
- Inova Fairfax Medical Campus Inova Health Systems
-
Kontakt:
- Bhruga Shah
- E-Mail: Bhruga.shah@inova.org
-
Hauptermittler:
- Kendal Endicott, MD
-
Norfolk, Virginia, Vereinigte Staaten, 23507
- Rekrutierung
- Sentara Health
-
Hauptermittler:
- David Dexter, MD
-
Kontakt:
- Angela Zahn
- E-Mail: AXZAHN@sentara.com
-
-
Washington
-
Seattle, Washington, Vereinigte Staaten, 98104
- Rekrutierung
- University of Washington at Harborview Medical Center
-
Kontakt:
- Allison Larimore
- E-Mail: alari@uw.edu
-
Hauptermittler:
- Benjamin Starnes, MD
-
-
Wisconsin
-
Green Bay, Wisconsin, Vereinigte Staaten, 54301
- Rekrutierung
- Bellin Memorial Hospital
-
Hauptermittler:
- Jason Ricci, MD
-
Kontakt:
- Katie Guilliams
- E-Mail: Katherine.Guilliams@emplifyhealth.org
-
-
Teilnahmekriterien
Zulassungskriterien
Studienberechtigtes Alter
Akzeptiert gesunde Freiwillige
Studienberechtigte Geschlechter
Beschreibung
Inclusion Criteria:
- Males and females ≥21 to ≤85 years of age. Females must be of non-childbearing potential (menopause or sterilization).
- Subject understands the purpose of the trial, agrees to voluntarily participate in the trial, signs the informed consent and is willing to complete the follow-up according to the requirements of the protocol.
- Infrarenal atherosclerotic fusiform abdominal aortic aneurysm from 3.5 cm to 5.0 cm (male) and 3.5 cm to 4.5 cm (female).
- Infrarenal aortic neck ≥ 15 mm in length and ≤ 29 mm in diameter.
- Overall AAA treatment length (distal renal to distal inferior margin of the aneurysm) not to exceed 130 mm.
- Iliac and femoral artery access, vessel size and morphology allow endovascular access of 14F (or larger) introducer sheaths and catheters.
- Subject meets American Society of Anesthesiology (ASA) grade 1 through 3 criteria, inclusive.
- Subject has > three-year life expectancy.
- Subject is able and willing to comply with all required follow-up clinic visits including CT scans (pre-randomization, 6, 12, 18, 24 months and annually up to 5 years) and blood draws.
Exclusion Criteria:
- Subject has an acutely ruptured, leaking, dissecting or emergent aneurysm.
- Subject has a symptomatic infrarenal abdominal aortic aneurysm.
- Subject has a mycotic or infected aneurysm.
- Subject has current vascular injury due to trauma.
- Subject's aneurysm is thoracic, suprarenal or juxtarenal.
- Previous surgical or endovascular aneurysm repair for abdominal aortic aneurysm.
- Subject has anatomy of diffuse, ulcerated, or extensive (shaggy) thrombus in the neck of the AAA, that in the opinion of the vascular surgeon/investigator, could result in embolization of the thrombus.
- Subject has anatomy of calcification, and/or plaque within the ilio-femoral arteries or severe infrarenal neck angulation that may compromise or does not allow delivery of the Introducer Sheath or the delivery catheter of the Nectero EAST System.
- Subject has had a myocardial infarction within six (6) months prior to enrollment or elevated CK enzymes or troponin indicative of an evolving MI prior to procedure.
- Subject has current angina, unstable angina, or other active cardiac condition such as congestive heart failure III and IV, atrial arrhythmia, ventricular arrhythmia, or valvular disease, requiring intervention.
- Subject has undergone other major surgery within the 30 days prior to enrollment.
- Subjects with any transient ischemic attack (TIA) or ischemic stroke within 3 months.
- Known allergy to contrast material that cannot be adequately premedicated, delivery system materials (i.e., nylon, polyurethane) and/or pentagalloylglucose (PGG).
- Subject is morbidly obese or has other clinical conditions that severely inhibit X-ray visualization of the aorta.
- Subject has connective tissue/collagen disorder (e.g., Marfan syndrome, vascular Ehlers-Danlos Syndrome, Loeys-Dietz Syndrome, Eaton Syndrome, Bessel-Hagen disease, etc.).
- Known contraindication to undergoing angiography or receiving systemic anticoagulation during the procedure.
- Subject has active systemic infection.
- Subject is participating in another research trial that could interfere with the results of the trial (e.g., drug trial).
- Subject has other medical, social, or psychological problems that, in the opinion of the investigator, preclude them from participation in the trial and to undergo the procedures and evaluations pre- and post-treatment.
- Subject has dialysis dependent renal failure or baseline serum creatinine level >2.5mg/dL or eGFR < 45 mL/min/1.73m2.
- Subjects with aminotransferase (ALT and/or AST) which is ≥1.5x upper limit of normal (ULN) or TB that is our of normal range for the evaluating laboratory.
- Subjects that may not tolerate the lowering of their systolic blood pressure to approximately 100mmHg, should not be considered for this study or treated using the Nectero EAST System.
- Subjects that may not be able to tolerate transient occlusion of the aorta should not be considered for this study.
- Subjects with saccular AAA.
- Subjects with rapidly expanding AAA (previous diameter increases of ≥0.5 cm in 6-months or ≥1 cm in 1 year) as these should be evaluated for immediate repair.
- Subjects who are not suitable for the Nectero EAST System treatment, as determined by the investigator.
- Subjects with INR out of normal range for the evaluating laboratory for a subject not on anti-coagulant therapy; or INR >3 for a subject on anti-coagulant therapy.
- Subjects with active/acute or a history of unstable chronic liver disease or current liver disease including but not limited to liver transplant, known genetic disorders such as Gilbert syndrome or other liver diseases.
- Subjects with cirrhosis (e.g., known history or new clinical diagnosis by elastography with a fibrosis score of F3 or F4 and/or steatosis grade of S3).
- Subjects with uncontrolled alcohol use disorder or current alcohol use putting them at risk of liver disease: including consumption of above one standard drink per day for women and two standard drinks per day for men.
- Subjects with known right-sided heart failure or pathologically dilated inferior vena cava or hepatic veins indicative of congestive hepatopathy.
Studienplan
Wie ist die Studie aufgebaut?
Designdetails
- Hauptzweck: Behandlung
- Zuteilung: Zufällig
- Interventionsmodell: Parallele Zuordnung
- Maskierung: Single
Waffen und Interventionen
Teilnehmergruppe / Arm |
Intervention / Behandlung |
|---|---|
|
Experimental: Treatment Arm
Participants assigned to the treatment arm will undergo an endovascular procedure using the Nectero EAST System to deliver the Stabilizer Infusion Solution directly inside the aneurysm. This is a one-time local delivery of the product. Following treatment, surveillance of their AAA will be conducted using CT scans at 6 months, 12 months, 18 months, 24 months, and annually for 5 years. Intervention: Drug: Stabilizer |
Treated subjects will undergo an endovascular procedure with the Nectero EAST system and receive the Stabilizer Infusion Solution (drug) within 30 days of the study eligibility by CT scan as a one-time local delivery of the drug. |
|
Kein Eingriff: Control Arm
Participants assigned to the control arm will undergo surveillance of their AAA using CT scans at 6 months, 12 months, 18 months, 24 months, and annually for 5 years. |
Was misst die Studie?
Primäre Ergebnismessungen
Ergebnis Maßnahme |
Maßnahmenbeschreibung |
Zeitfenster |
|---|---|---|
|
Primary Endpoint
Zeitfenster: 24 months
|
The primary endpoint is the composite of all AAA-related death, rupture and repair (open-surgical, EVAR, or clinically indicated for repair as adjudicated by a committee of clinical experts blinded to the assigned arm). |
24 months
|
Sekundäre Ergebnismessungen
Ergebnis Maßnahme |
Maßnahmenbeschreibung |
Zeitfenster |
|---|---|---|
|
Growth
Zeitfenster: 24 months
|
The growth over time in aneurysm diameter based on CT core laboratory readings. |
24 months
|
Mitarbeiter und Ermittler
Sponsor
Ermittler
- Hauptermittler: Daniel Clair, MD, Vanderbilt University Medical Center
- Hauptermittler: Grace Wang, MD, University of Pennsylvania
Publikationen und hilfreiche Links
Nützliche Links
Studienaufzeichnungsdaten
Haupttermine studieren
Studienbeginn (Tatsächlich)
Primärer Abschluss (Geschätzt)
Studienabschluss (Geschätzt)
Studienanmeldedaten
Zuerst eingereicht
Zuerst eingereicht, das die QC-Kriterien erfüllt hat
Zuerst gepostet (Tatsächlich)
Studienaufzeichnungsaktualisierungen
Letztes Update gepostet (Tatsächlich)
Letztes eingereichtes Update, das die QC-Kriterien erfüllt
Zuletzt verifiziert
Mehr Informationen
Begriffe im Zusammenhang mit dieser Studie
Schlüsselwörter
Zusätzliche relevante MeSH-Bedingungen
Andere Studien-ID-Nummern
- EAST002
Arzneimittel- und Geräteinformationen, Studienunterlagen
Studiert ein von der US-amerikanischen FDA reguliertes Arzneimittelprodukt
Studiert ein von der US-amerikanischen FDA reguliertes Geräteprodukt
Diese Informationen wurden ohne Änderungen direkt von der Website clinicaltrials.gov abgerufen. Wenn Sie Ihre Studiendaten ändern, entfernen oder aktualisieren möchten, wenden Sie sich bitte an register@clinicaltrials.gov. Sobald eine Änderung auf clinicaltrials.gov implementiert wird, wird diese automatisch auch auf unserer Website aktualisiert .